924909-75-1

Basic information

• Product Name: Minozac Dihydrochloride
• Synonyms: Minozac Dihydrochloride
• CAS NO: 924909-75-1
• Molecular Formula: C19H20N6
• Molecular Weight: 332.4023
• Product Categories: Heterocycles, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 924909-75-1.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Minozac Dihydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: Minozac Dihydrochloride(924909-75-1)
• EPA Substance Registry System: Minozac Dihydrochloride(924909-75-1)

Safety Data

• Hazardous Substances Data: 924909-75-1(Hazardous Substances Data)

Usage

Uses

Minozac maintains the ability to suppress brain proinflammatory cytokine up-regulation.

Upstream product

• 1771-65-9 2-methyl-4-oxo-4-phenylbutanoic acid 
• 52239-91-5 4-methyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one 
• 13300-09-9 4-methyl-6-phenylpyridazin-3(2H)-one 
• 28657-39-8 3-chloro-4-methyl-6-phenylpyridazine 
• 886208-65-7 Minozac 

Relevant articles and documents

FORMULATIONS CONTAINING PYRIDAZINE COMPOUNDS

The invention relates to chemical compounds, compositions and methods of making and using the same. In particular, the invention provides selected pyridazine compounds of the formula I are independently hydrogen, hydroxyl, alkyl, alkenyl, alkynyl, alkylene, alkenylene, alkoxy, alkenyloxy, cycloalkyl, cycloalkenyl, cycloalkynyl, cycloalkoxy, aryl, aryloxy, arylalkoxy, aroyl, heteroaryl, heterocyclic, acyl, acyloxy, amino, imino, azido, thiol, thioalkyl, thioalkoxy, thioaryl, nitro, cyano, halo, sulfate, sulfenyl, sulfinyl, sulfonyl, sulfonate, sulfoxide, silyl, silyloxy, silylalkyl, silylthio, ═O, ═S, phosphonate, ureido, carboxyl, carbonyl, carbamoyl, or carboxamide; and X is optionally substituted pyrimidinyl or pyridazinyl, an isomer, a pharmaceutically acceptable salt, or derivative thereof. The invention additional relates to compositions comprising the compounds, and methods of using the compounds and compositions for modulation of cellular pathways, for treatment or prevention of inflammatory diseases, for research, drug screening, and therapeutic applications.